Download PDF
CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2022; 12(01): 93-95
DOI: 10.1055/s-0041-1731142
Case Report

An Atypical Case of Mild COVID-19 Infection with Severe Guillain-Barré Syndrome as Neurological Manifestation

Debasis Behera
1   Department of Pulmonary, Critical Care and Sleep Medicine, KIMS, Bhubaneswar, Odisha, India
,
Ruchi Rekha Behera
2   Department of Paediatrics, SCB Medical College, Cuttack, Odisha, India
,
Suman Kumar Jagaty
1   Department of Pulmonary, Critical Care and Sleep Medicine, KIMS, Bhubaneswar, Odisha, India
,
Rekha Das
3   Acharya Harihar Post Graduate Institute of Cancer, SCB Medical College, Cuttack, Odisha, India
,
Rajesh Venkataram
4   Department of Pulmonary Medicine, K.S. Hegde Medical Academy, Mangalore, Karnataka, India
,
Saswat Subhankar
1   Department of Pulmonary, Critical Care and Sleep Medicine, KIMS, Bhubaneswar, Odisha, India
,
Vikram Samal
2   Department of Paediatrics, SCB Medical College, Cuttack, Odisha, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Introduction More than 80 million people have been infected with coronavirus disease 2019 (COVID-19) infection worldwide till date with more than 17,00000 fatalities. Although COVID-19 commonly affects respiratory system in the form of cough and dyspnea, a neurotropic presentation has been described in one-third of patients.

Objective We report an atypical case of COVID-19 with mild symptoms who presented to our hospital with features suggestive of severe Guillain-Barré syndrome (GBS).

Discussion The mechanisms by which severe acute respiratory syndrome coronavirus 2 causes neurologic damage are multifactorial, including direct damage to specific receptors, cytokine-mediated injury, secondary hypoxia, and retrograde travel along nerve fibers. The pathogenesis of GBS secondary to COVID-19 is not yet well understood. It is hypothesized that viral illnesses-related GBS could be mediated due to autoantibodies or direct neurotoxic effects of viruses.

Conclusion In this ongoing era of pandemic, it is very important for the clinicians to be aware of association of GBS with COVID-19, as early diagnosis and treatment of this complication could have gratifying results. It is also very important to differentiate GBS from critical illness neuropathy and respiratory distress secondary to COVID-19 itself, as treatment to the above conditions is quite different and inability to correctly diagnose could lead to significant increase in morbidity and mortality.

Keywords

COVID-19 - GBS - AMSAN - lung collapse - bronchoscopy


Publication History

Article published online:
08 June 2021

© 2021. Nitte (Deemed to be University). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Coronavirus Disease (COVID-19) Situation Reports. Who. int. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Published 2021. Accessed May 16, 2021.
  • 2 Carrillo-Larco RM, Altez-Fernandez C, Ravaglia S, Vizcarra JA. COVID-19 and Guillain-Barre syndrome: a systematic review of case reports. Wellcome Open Res 2020; 5: 107 DOI: 10.12688/wellcomeopenres.15987.2.
    CrossrefPubMedGoogle Scholar
  • 3 Politi LS, Salsano E, Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol 2020; 77 (08) 1028-1029
    CrossrefPubMedGoogle Scholar
  • 4 Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med 2020; 38 (07) 1549.e3-1549.e7
    CrossrefPubMedGoogle Scholar
  • 5 Piccione EA, Salame K, Katirji B. Guillain-Barré syndrome and related disorders. In: Katirji B, Kaminski H, Ruff R, eds. Neuromuscular Disorders in Clinical Practice. New York, NY: Springer 2014
  • 6 Mao L, Jin H, Wang M. et al Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77 (06) 683-690
    CrossrefPubMedGoogle Scholar
  • 7 Toscano G, Palmerini F, Ravaglia S. et al Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med 2020; 382 (26) 2574-2576
    CrossrefPubMedGoogle Scholar
  • 8 Alberti P, Beretta S, Piatti M. et al Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm 2020; 7 (04) e741 DOI: 10.1212/nxi.0000000000000741.
    CrossrefPubMedGoogle Scholar
  • 9 Virani A, Rabold E, Hanson T. et al Guillain-Barré syndrome associated with SARS-CoV-2 infection. IDCases 2020; 20: e00771 DOI: 10.1016/j.idcr.2020.e00771.
    CrossrefPubMedGoogle Scholar
  • 10 Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris) 2020; 176 (06) 516-518
    CrossrefPubMedGoogle Scholar
  • 11 Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020; 11 (07) 995-998
    CrossrefPubMedGoogle Scholar